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Members of the *Bifidobacterium* genus are high-G+C Gram-positive bacteria that were first isolated and described over a century ago from the feces of breastfed infants ([@B1]). Since then, *Bifidobacterium* species have been isolated from the digestive tracts of various mammalian species, including human and mouse ([@B2][@B3][@B4]), insects ([@B5]), and birds ([@B6]), as well as from sewage and food, these two ecological niches being linked to contamination originating from the human/animal intestinal environments ([@B6], [@B7]). Because of their positive health benefits to the human host, *Bifidobacterium* bacteria have been the intense focus of industrial and scientific interests, mostly for their potential use as probiotics. However, the specific molecular cascades involved in the *Bifidobacterium*-host cross talks promoting these beneficial health effects remain largely unknown ([@B8], [@B9]).

The use of *in vivo* murine models to characterize the impact of specific members of the intestinal microbiota on the host physiology is a promising avenue for dissecting the key pathways involved in these interactions ([@B3], [@B10]). Among bifidobacteria, *Bifidobacterium pseudolongum* has been described as one of the most predominant *Bifidobacterium* species in the murine gastrointestinal tract, and its use in carefully designed animal studies could hold the key to identifying the host-microbiota molecular mechanisms impacting the host. Despite the availability of 386 *Bifidobacterium* whole-genome sequences in public databases (source: Genomes Online Database, queried on 1 August 2017), there has been no complete *B. pseudolongum* genome sequence obtained from a mouse isolate. The only complete *B. pseudolongum* genome sequence---for strain PV8-2 (GenBank accession number CP007457)---was isolated from feces of an anemic Kenyan infant ([@B11]).

Here, we report the complete genome sequence of *B. pseudolongum* strain UMB-MBP-01, isolated from the feces of C57BL/6J mice through passages and screening on Bifidus selective medium (BSM) agar (Sigma-Aldrich, St. Louis, MO, USA). This strain was identified in microbiome profiling studies associated with improved transplant outcome in a murine model of cardiac heterotypic transplantation E. F. Mongodin and J. S. Bromberg, unpublished data. Genomic DNA extraction was performed using a lysozyme/mutanolysin-based cell lysis followed by purification using the Wizard genomic DNA purification kit (Promega, Madison, WI, USA). Library construction (5- to 20-kb-long insert) and sequencing were performed at the University of Maryland's Institute for Genome Sciences using one single-molecule real-time (SMRT) cell on a PacBio RS II system (Pacific Biosciences, Menlo Park, CA, USA). A total of 159,138 reads with an average length of 4,598 bp (total bases, 731,667,147 bp) were assembled into a single contig (chromosome) using the Hierarchical Genome Assembly Process (HGAP) assembler. The genome was then automatically annotated using the IGS Prokaryotic Annotation Pipeline ([@B12]). The genome of *B. pseudolongum* strain UMB-MBP-01 consists of a 2,008,102-bp circular chromosome containing 52 tRNA genes and 4 rRNA operons encoding 12 rRNA genes. The G+C content of the genome is 63.4%, and a total of 1,697 protein-coding sequences were predicted. Preliminary analyses using the BLAST score ratio comparison tool ([@B13]) showed that 271 predicted genes in the UMB-MBP-01 genome (15.96% of the genome) do not have homologs in the PV8-2 genome. This set of genes could be involved in murine host colonization and/or anti-inflammatory properties of our UMB-MBP-01 isolate.
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The *B. pseudolongum* UMB-MBP-01 complete genome sequence is available under GenBank accession number [CP022544](http://www.ncbi.nlm.nih.gov/nuccore/CP022544).
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